Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001641172-25-024130
Filing Date
2025-08-14
Accepted
2025-08-14 16:56:45
Documents
1
Period of Report
2025-06-30
Effectiveness Date
2025-08-14

Document Format Files

Seq Description Document Type Size
1 NT 10-Q formnt10-q.htm NT 10-Q 35031
  Complete submission text file 0001641172-25-024130.txt   36405
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-12555 | Film No.: 251220580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)